Reply to R. Bhargava et al and K. Lambein et al

J Clin Oncol. 2014 Jun 10;32(17):1857-9. doi: 10.1200/JCO.2014.55.0673. Epub 2014 Apr 28.

Authors

Antonio C Wolff¹, M Elizabeth H Hammond², David G Hicks³, Mitch Dowsett⁴, Daniel F Hayes⁵, Lisa M McShane⁶

Affiliations

¹ The Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, MD.
² University of Utah School of Medicine and Intermountain Healthcare, Salt Lake City, UT.
³ University of Rochester Medical Center, Rochester, NY.
⁴ Royal Marsden Hospital, London, United Kingdom.
⁵ University of Michigan Comprehensive Cancer Care Center, Ann Arbor, MI.
⁶ National Cancer Institute, Bethesda, MD.

PMID: 24778389
DOI: 10.1200/JCO.2014.55.0673

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Biomarkers, Tumor*
Breast Neoplasms / genetics*
Breast Neoplasms / metabolism*
ErbB Receptors / biosynthesis*
ErbB Receptors / genetics*
Female
Genes, erbB-2*
Humans

Substances

Biomarkers, Tumor
ErbB Receptors